Bank of New York Mellon
TSHA icon

Bank of New York Mellon’s Taysha Gene Therapies TSHA Stock Holding History

Bank of New York Mellon’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.75M Buy
697,971
+89,848
+15% +$532K ﹤0.01% 2467
2026
Q1 		$2.72M Sell
608,123
-16,244
-3% -$75.5K ﹤0.01% 2659
2025
Q4 		$3.43M Sell
624,367
-472
-0.1% -$2.29K ﹤0.01% 2530
2025
Q3 		$2.04M Buy
624,839
+166,180
+36% +$471K ﹤0.01% 2799
2025
Q2 		$1.06M Buy
458,659
+5,239
+1% +$11.4K ﹤0.01% 3097
2025
Q1 		$630K Buy
453,420
+3,159
+0.7% +$5.28K ﹤0.01% 3336
2024
Q4 		$779K Buy
450,261
+111,989
+33% +$232K ﹤0.01% 3292
2024
Q3 		$680K Sell
338,272
-116,192
-26% -$255K ﹤0.01% 3342
2024
Q2 		$1.02M Buy
+454,464
New +$1.32M ﹤0.01% 3192
2024
Q1 		– Sell
-58,140
Closed -$103K – 4315
2023
Q4 		$103K Buy
58,140
+32,066
+123% +$63.9K ﹤0.01% 4077
2023
Q3 		$82.4K Buy
+26,074
New +$48.7K ﹤0.01% 4106
2022
Q4 		– Sell
-11,295
Closed -$22K – 4553
2022
Q3 		$22K Sell
11,295
-375
-3% -$1.36K ﹤0.01% 4446
2022
Q2 		$44K Sell
11,670
-66,567
-85% -$264K ﹤0.01% 4377
2022
Q1 		$510K Buy
78,237
+2,067
+3% +$15.5K ﹤0.01% 3699
2021
Q4 		$887K Buy
76,170
+2,425
+3% +$36.6K ﹤0.01% 3448
2021
Q3 		$1.37M Buy
73,745
+17,073
+30% +$325K ﹤0.01% 3218
2021
Q2 		$1.2M Buy
56,672
+29,740
+110% +$686K ﹤0.01% 3297
2021
Q1 		$546K Sell
26,932
-48
-0.2% -$1.3K ﹤0.01% 3645
2020
Q4 		$716K Buy
+26,980
New +$581K ﹤0.01% 3446

Other funds holding TSHA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
AWM
Affinity Wealth Management Wilmington, Delaware $776M AUM 43.59% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon's TSHA Position: Q2 2026 in Review

Bank of New York Mellon increased its Taysha Gene Therapies (TSHA) stake by 15% in Q2 2026, buying an estimated $532K and bringing the position to 697,971 shares worth $4.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

Bank of New York Mellon first reported a position in TSHA in Q4 2020 and has held it in 19 quarters since. 80 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Bank of New York Mellon held 697,971 shares of Taysha Gene Therapies worth $4.75M as of Q2 2026.
  • Bank of New York Mellon bought 89,848 Taysha Gene Therapies shares in Q2 2026, an estimated $532K.
  • Taysha Gene Therapies made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2467 holding.
  • Bank of New York Mellon first reported a position in Taysha Gene Therapies in Q4 2020 and has held it in 19 quarters since.
  • 80 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.